Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) can potentiate all 3 sides of Virchow’s Triad of coagulopathy, including endothelial dysfunction, blood flow stasis, and hypercoagulability. Angiotensin-converting enzyme-2 (ACE-2)–dependent viral entry and the virus-induced inflammatory response can lead to endothelial dysfunction. Clotting Prevention in COVID-19 Patients, Thrombosis Prevention in COVID-19 Patients, Preventing blood clots in COVID-19 patients
Feature | Antiplatelet and Anticoagulation Therapies | By Dave Fornell, Editor

A comprehensive review or more than 80 randomized controlled trials (RCTs) investigating how to best manage optimal ...

Home March 22, 2021
Home
Videos | Ventricular Assist Devices (VAD)

Surgeons at Penn State Heart and Vascular Institute were the second group in the nation to implant a newly-designed ...

Home March 22, 2021
Home
News | Heart Valve Technology

March 18, 2020 — A groundbreaking new study led by University of Minnesota Twin Cities researchers from both the College ...

Home March 18, 2021
Home
News | Point-of-Care Ultrasound (POCUS)

March 18, 2021 — GE Healthcare this week unveiled Vscan Air, a cutting-edge, wireless pocket-sized ultrasound that ...

Home March 18, 2021
Home
News | Interventional Radiology

March 18, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Boston Scientific's TheraSphere Y-90 Glass ...

Home March 18, 2021
Home
Integrating data from an array of implantable EP devices from different vendors can be difficult or require disconnected silos of data for different vendors. One solution that was recently introduced to integrate data from various vendors is the Optimize EP software, which allows viewing data from all device vendors in one platform to streamline workflows.
Feature | EP Lab | By Maninder Bedi, M.D.

A few weeks ago, a patient of mine experienced a cardiac event — his heart stopped. Completely. However, his implantable ...

Home March 17, 2021
Home
News | Coronavirus (COVID-19)

March 17, 2021 — Around 50% of patients who have been hospitalized with severe COVID-19 (SARS-CoV-2) and have damage to ...

Home March 17, 2021
Home
Blog | Cath Lab

After covering cardiovascular technologies for 14 years, it is rare that I find a new technology that might actually be ...

Home March 16, 2021
Home
Cloud AI software-as-a-service (SaaS) can help streamline workflows and increase throughput, enabling echocardiographers to better measure global longitudinal strain (GLS) more routinely without impacting productivity. This is an example of the Ultromics EchoGo Core artificial intelligence algorithm with fully automates GLS.
Feature | Artificial Intelligence

Heart failure (HF) is a prevalent yet silent epidemic, affecting 26 million people and costing global healthcare systems ...

Home March 16, 2021
Home
Example of an angioplasty balloon catheter being expanded inside an artery to push atherosclerotic plaque and thrombus out of the way to reopen the vessel lumen to increase or reopen bloodflow. Balloon catheters are used to revascularize patients with heart attacks and to deploy stents to prop open the expended vessel.
Feature | Balloon Catheter | By Dave Fornell, Editor

The first devices developed for interventional cardiology were percutaneous transluminal coronary angioplasty (PTCA) ...

Home March 16, 2021
Home
A study from Washington University School of Medicine in St. Louis provides evidence that the coronavirus can invade and replicate inside heart muscle cells, causing cell death and interfering with heart muscle contraction. The image of engineered heart tissue shows human heart muscle cells (red) infected with COVID-19 (SARS-CoV-2) (green). Image by Lina Greenberg.
Feature | Coronavirus (COVID-19)

March 12, 2021 — Since early in the pandemic, COVID-19 has been associated with heart problems, including reduced ...

Home March 12, 2021
Home
News | Drug-Eluting Balloons

March 12, 2021 — Philips Healthcare announced the final, five-year results of two major randomized controlled trials ...

Home March 12, 2021
Home
News | Coronavirus (COVID-19)

March 12, 2021 — A new review suggests that blood vessel damage and impaired oxygen delivery related to COVID-19 play a ...

Home March 12, 2021
Home
News | Cardiovascular Business

March 12, 2021 — Cardinal Health today announced that it is selling its Cordis cardiology and endovascular business to ...

Home March 12, 2021
Home
An example of intra-cardiac echo (ICE) imaging from Siemens Healthineers showing color flow Doppler with severe valve regurgitation. ICE has seen wider use in transcatheter structural heart  procedures because, unlike TEE, it can be used without deeper sedation of anesthesia.
Feature | Ultrasound Intra-cardiac Echo (ICE) | By Dave Fornell, Editor

Intra-cardiac Echocardiography (ICE) uses catheter-based cardiac ultrasound array to image anatomy and devices inside ...

Home March 11, 2021
Home
Subscribe Now